title: Evaluating treatments and corresponding costs of prostate cancer patients treated within an inpatient or hospital-based outpatient setting.
abstract: OBJECTIVE
  To describe treatments and cost of care for prostate cancer (PCa) in hospital-based outpatient and inpatient settings.
  
  
  METHODS
  Hospital encounters associated with PCa (ICD-9 codes 185, 233.4) and PCa-related treatment in a hospital claims database were included.
  
  
  RESULTS
  There were 211,440 encounters for PCa between January 2006 and December 2010 (88,151 inpatient and 123,289 outpatient). Average cost per inpatient stay was US$12,286 versus US$4364 per outpatient visit. Most common treatment during an inpatient stay and outpatient visit was surgery (57%) and radiation (76%), respectively. A total of 80% of outpatient visits and 69.9% inpatient stays were associated with a single treatment; remaining encounters were associated with ≥2 treatments.
  
  
  CONCLUSIONS
  Costs are consistent with previous estimates; however, multimodal therapy is an emerging trend that may be related to greater costs in the future which may also be a challenge for hospital decision makers.
authors: Bayer HealthCare Pharmaceuticals, 100 Bayer Boulevard Whippany, NJ 07981, USA.
authors: Brian
authors: B
authors: Seal
authors: Sean D
authors: SD
authors: Sullivan
authors: Scott
authors: S
authors: Ramsey
authors: Carl V
authors: CV
authors: Asche
authors: Kenneth M
authors: KM
authors: Shermock
authors: Syam
authors: S
authors: Sarma
authors: Erin
authors: E
authors: Zagadailov
authors: Eileen
authors: E
authors: Farrelly
authors: Michael
authors: M
authors: Eaddy
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D016208:Databases, Factual; D017048:Health Care Costs; D006760:Hospitalization / Q000191:economics; D006801:Humans; D007297:Inpatients; D008297:Male; D008875:Middle Aged; D010045:Outpatients; D011471:Prostatic Neoplasms / Q000453:epidemiology* / Q000628:therapy; D014481:United States / Q000453:epidemiology
keywords: healthcare costs/trends; hospitalization; prostatic neoplasms; retrospective studies